Literature DB >> 16884734

A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.

Wannee Kantakamalakul1, Kovit Pattanapanyasat, Surat Jongrakthaitae, Vatcharain Assawadarachai, Silawun Ampol, Ruengpung Sutthent.   

Abstract

Enhanced green fluorescent protein (EGFP) was stably expressed in CEM-NKr cell, a natural killer (NK) resistant human T-lymphoblastoid cell line, as EGFP-CEM-NKr cells. The cells pulsed with HIV-1 gp120 were then used as target cells for the measurement of antibody dependent cell mediated-cytotoxicity (ADCC) by flow cytometry. Compromised EGFP-CEM-NKr target cells stained with propidium iodide (PI) showed dual (green-red) fluorescent. Kinetic studies demonstrated that the sum of ADCC activity measured at 1-h and again at 2-h incubations by this flow cytometric method was comparable to the activity at 6 h by the standard chromium (51Cr) release assay (CRA). ADCC activity of HIV-1 seropositive sera measured by this new technique correlated strongly with that of CRA (Pearson's correlation coefficient of 0.832; p-value < 0.001 and intraclass correlation coefficient of 0.903; p-value < 0.001). The EGFP-CEM-NKr stable cell line provides a novel method to measure ADCC activity to HIV-1 gp120 by flow cytometry without pre-staining or pre-labeling target cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884734     DOI: 10.1016/j.jim.2006.06.005

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.

Authors:  Mariana M Mata; Fareeha Mahmood; Ryan T Sowell; Linda L Baum
Journal:  J Immunol Methods       Date:  2014-02-20       Impact factor: 2.303

2.  A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.

Authors:  Michael D Alpert; Lisa N Heyer; David E J Williams; Jackson D Harvey; Thomas Greenough; Maria Allhorn; David T Evans
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

3.  Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG.

Authors:  Raymond A Alvarez; Ana M Maestre; Kenneth Law; Natasha D Durham; Maria Ines Barria; Akiko Ishii-Watabe; Minoru Tada; Manav Kapoor; Mathew T Hotta; Gabriela Rodriguez-Caprio; Daniel S Fierer; Ana Fernandez-Sesma; Viviana Simon; Benjamin K Chen
Journal:  JCI Insight       Date:  2017-02-23

4.  A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.

Authors:  Chiara Orlandi; Robin Flinko; George K Lewis
Journal:  J Immunol Methods       Date:  2016-03-08       Impact factor: 2.303

Review 5.  Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.

Authors:  Bruce D Wines; Hugh Billings; Milla R Mclean; Stephen J Kent; P Mark Hogarth
Journal:  Curr HIV Res       Date:  2017       Impact factor: 1.581

6.  Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.

Authors:  Shiwei Xu; Margaret C Carpenter; Rachel L Spreng; Scott D Neidich; Sharanya Sarkar; DeAnna Tenney; Derrick Goodman; Sheetal Sawant; Shalini Jha; Brooke Dunn; M Juliana McElrath; Valerie Bekker; Sarah V Mudrak; Robin Flinko; George K Lewis; Guido Ferrari; Georgia D Tomaras; Xiaoying Shen; Margaret E Ackerman
Journal:  NPJ Vaccines       Date:  2022-08-04       Impact factor: 9.399

7.  Development of a Macrophage-Based ADCC Assay.

Authors:  Melissa B Uccellini; Sadaf Aslam; Sean T H Liu; Fahmida Alam; Adolfo García-Sastre
Journal:  Vaccines (Basel)       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.